论文部分内容阅读
近年来高脂血症逐年增加,长期控制血脂水平,可以减缓冠心病的发生与发展。现将我们应用血脂康治疗26例中年人高脂血症患者的疗效报道如下。
In recent years, hyperlipidemia increased year by year, long-term control of blood lipid levels, can slow down the occurrence and development of coronary heart disease. Now we apply Xuezhikang treatment of 26 cases of middle-aged patients with hyperlipidemia efficacy reported below.